Related by context. All words. (Click for frequent words.) 84 Patients Treated With 83 Improves Survival 82 Elderly Patients 81 Improves Outcomes 81 Metastatic Colorectal Cancer 81 Survival Benefit 81 Patients Undergoing 81 Patients Receiving 80 Phase III Trial 80 Monotherapy 80 Previously Treated 80 Cardiovascular Events 80 Meets Primary Endpoint 80 Advanced Prostate Cancer 80 Advanced Melanoma 79 Pediatric Patients 79 Well Tolerated 79 Heart Failure Patients 79 Rheumatoid Arthritis Patients 79 Renal Cell Carcinoma 79 Clinical Trial Results 79 Is Well Tolerated 79 Unfractionated Heparin 79 Chronic Hepatitis C 79 Statin Therapy 79 Completes Enrollment 78 Relapsing Multiple Sclerosis 78 Appears Safe 78 Phase III Clinical Trial 78 Study Evaluating 78 Significantly Reduced 78 Newly Diagnosed Multiple Myeloma 78 Combination Therapy 78 Combination Treatment 78 Demonstrates Significant 78 Previously Untreated 78 Study Showed 78 Pooled Analysis 78 Study Demonstrates 78 Improved Survival 78 Prolongs Survival 78 Phase IIb Trial 78 Adjuvant Chemotherapy 78 Adjuvant Therapy 77 Treated Patients 77 Antitumor Activity 77 Bare Metal Stents 77 HER2 Positive Breast Cancer 77 Postmenopausal Women 77 Diabetic Patients 77 Colorectal Cancer Patients 77 Relapsed Multiple Myeloma 77 Adjuvant Treatment 77 Statistically Significant 77 Disease Progression 77 Long Term Efficacy 77 Radical Prostatectomy 77 Hypertensive Patients 77 Drug Candidate 77 Clinical Trial Evaluating 77 Knee Osteoarthritis 77 Demonstrates Efficacy 77 Tolerability 77 Improve Survival 76 Patients Enrolled 76 Dialysis Patients 76 Phase 2b Clinical Trial 76 Single Dose 76 Epoetin Alfa 76 Plus Ribavirin 76 Investigational Agent 76 Significantly Reduces 76 Metastatic Prostate Cancer 76 Resistant Hypertension 76 Ischemic Stroke 76 Stent Implantation 76 Hepatitis C Patients 76 Hemodialysis Patients 76 Chronic Hepatitis B 76 Anti Tumor Activity 76 Demonstrates Positive 76 Prostate Cancer Patients 76 Castration Resistant Prostate Cancer 76 Inhaled Corticosteroids 76 Versus Placebo 76 Overactive Bladder 76 Acute Ischemic Stroke 76 Pivotal Trial 76 FDA Approvals 75 Severe Sepsis 75 Carotid Stenting 75 Relapsed Refractory 75 Peginterferon 75 Receives Orphan Drug Designation 75 Multiple Myeloma Patients 75 II Clinical Trial 75 Lung Cancer Patients 75 Infected Patients 75 Shows Efficacy 75 Acute Myocardial Infarction 75 Subgroup Analysis 75 Obese Patients 75 Trial Evaluating 75 Long Term Outcomes 75 Oral Fingolimod 75 Investigational Compound 75 Preclinical Data 75 Increased Risk 75 Phase 2b Study 75 Controlled Study 75 Phase III Trials 75 Adjunctive Therapy 75 Hormone Refractory Prostate Cancer 75 Zoledronic Acid 75 Demonstrated Significant 75 Breast Cancer Recurrence 75 Relapsing Remitting Multiple Sclerosis 75 Fracture Risk 74 Venous Thromboembolism 74 Randomized Clinical Trial 74 Increases Risk 74 Localized Prostate Cancer 74 Hepatitis C Genotype 74 Controlled Trial 74 Treatment Naive Patients 74 Clinical Efficacy 74 Node Positive 74 Breast Cancer Patients 74 Proves Effective 74 Chronic Sinusitis 74 Drug Eluting 74 Patients Suffering 74 Completes Patient Enrollment 74 Autologous Stem Cell Transplantation 74 Low Dose 74 Significantly Improves 74 Complicated Skin 74 Pivotal Phase III 74 Chemoradiation 74 Peginterferon Alfa 2a 74 Randomized Study 74 Shows Promise 74 Proven Effective 74 Metastatic Renal Cell Carcinoma 74 Advanced Colorectal Cancer 74 Pivotal Phase 74 Phase IIb Clinical Trial 74 Investigational Drug 74 Advanced Pancreatic Cancer 74 Treatment Naive 74 Postmenopausal Osteoporosis 74 Hormone Receptor Positive 74 Investigational Treatment 74 Pivotal Study 74 Significantly Improved 73 Kidney Transplant Patients 73 Androgen Deprivation Therapy 73 Reduces Risk 73 Treatment Reduces 73 Treatment Naïve Patients 73 Kidney Transplant Recipients 73 FDA Okays 73 Fixed Dose 73 Phase 2b Trial 73 Cardiovascular Outcomes 73 Prophylactic Treatment 73 JAK Inhibitor 73 Tiotropium 73 Sustained Efficacy 73 Myelodysplastic Syndromes 73 Treating Chronic 73 Myeloma Patients 73 Efficacious 73 Cholesterol Lowering Drug 73 Phase 2a Clinical Trial 73 Demonstrates Potential 73 FDA Clears 73 Dual Antiplatelet Therapy 73 Drug Shows Promise 73 Non Inferiority 73 Data Suggest 73 Prospective Randomized 73 Osteoporosis Drug 73 Reduced Risk 73 Sirolimus Eluting Stent 73 Relapsed 73 Slows Progression 73 Slow Progression 73 Clinical Outcome 73 Kidney Function 73 Liver Failure 73 Soft Tissue Sarcoma 73 Patient Enrollment 73 Radiofrequency Ablation 73 FDA Approves 73 Novel Oral 73 Lung Cancer Trial 73 Protease Inhibitor 73 Viral Suppression 73 Survival Rates 73 Capecitabine 73 Fungal Infections 73 Granted Orphan Drug 73 HER2 Positive 73 Randomized Trials 73 Lowers Risk 73 Beta Blockers 73 Demonstrates Potent 73 Advanced Ovarian Cancer 73 Viral Load 73 Complete Remission 73 Stent Restenosis 73 Metastatic Melanoma 73 Breast Cancers 73 Osteoporosis Treatment 72 Platelet Inhibition 72 Advanced Renal Cell 72 Gastric Cancer 72 Effective Than 72 Reduces Mortality 72 Shows Promising 72 Increased Mortality 72 Pegylated Liposomal Doxorubicin 72 Improve Outcomes 72 Non Responders 72 Randomized Double Blind 72 Fewer Side Effects 72 Glucose Control 72 HCV Protease Inhibitor 72 Meta Analysis 72 Effectively Treats 72 Partial Onset Seizures 72 Placebo Controlled Study 72 Present Preclinical Data 72 Cyclophosphamide 72 Neoadjuvant 72 Reduced Incidence 72 Beneficial Effects 72 Medoxomil 72 Secondary Hyperparathyroidism 72 Malignant Melanoma 72 Anticancer Activity 72 Pharmacokinetic Study 72 Immunosuppression 72 Placebo Controlled Trial 72 Pivotal Trials 72 Breast Cancer Treatment 72 Osteoporosis Drugs 72 Cutaneous T 72 Phase IIa Clinical Trial 72 Inhibits 72 Randomized Phase 72 Ovarian Cancer Patients 72 Nilotinib 72 Boosts Survival 72 Brain Metastases 72 Double Blind Placebo 72 Renal Impairment 72 Efficacy Trial 72 Multicenter Trial 72 Pegylated Interferon 72 Induction Therapy 72 Shows Promise Against 72 Glatiramer Acetate 72 Mouse Model 72 Fluorouracil 72 Lung Cancers 72 Premature Infants 72 NDA Submission 72 Initiate Phase III 72 Treatment Resistant 72 Insulin Glargine 72 Kidney Transplants 72 Tumor Growth 71 Bone Metastases 71 Carboplatin Paclitaxel 71 Hemoglobin Levels 71 Liver Metastases 71 Blood Clots 71 Lung Cancer Survival 71 ORLive Presents 71 Diuretic 71 ST Elevation Myocardial 71 Bosutinib 71 Treatment Experienced 71 First Patient Dosed 71 Randomized Controlled Trial 71 Drug Combo 71 Bone Mineral Density 71 Atypical Hemolytic Uremic Syndrome 71 Critically Ill Patients 71 Higher Doses 71 Gene Variant 71 Plaque Psoriasis 71 Receives FDA Clearance 71 Pivotal Clinical Trial 71 Premenopausal Women 71 Glycemic Control 71 Stem Cell Treatment 71 Renal Anemia 71 Disease Modifying 71 Left Ventricular Hypertrophy 71 Anthracycline 71 Gene Mutation 71 Treatment Regimen 71 Adefovir 71 Commonly Used 71 Physical Function 71 Prostate Cancer Treatment 71 Lupus Nephritis 71 Rectal Cancer 71 Initiates Clinical Trial 71 Unresectable 71 Invasive Breast Cancer 71 Enoxaparin 71 Diabetic Neuropathy 71 Patient Outcomes 71 Chronic Constipation 71 Anti Tumor 71 Antiviral Activity 71 Bevacizumab 71 Initiate Clinical Trial 71 Successfully Treated 71 Study Proves 71 Generic Version 71 Refractory Hodgkin Lymphoma 71 Sustained Reduction 71 Hepatocellular Carcinoma 71 Less Invasive 71 Lupus Drug 71 Study Indicates 71 Orally Active 71 Phase 2a Trial 71 Bivalirudin 71 Total Knee Arthroplasty 71 Stent Thrombosis 71 Arthritis Drug 71 Transdermal Patch 71 Neoadjuvant Chemotherapy 71 Renal Function 71 Psoriasis Patients 71 Peginterferon Alfa 2b 71 Contrast Agents 71 Newly Diagnosed 71 ACE Inhibitors 71 Follicular Lymphoma 71 Initiates Phase III 71 Spectrum Pharmaceuticals Announces 71 Submits NDA 70 Vertebral Compression Fractures 70 Cell Transplants 70 Therapy Improves 70 Allergic Rhinitis 70 Gout Drug 70 Chemotherapy Improves 70 Study Shows Promise 70 Treatment Naïve 70 Naive Patients 70 Gastric Ulcers 70 Patient Treated 70 Dose Escalation 70 Beta Blocker 70 Subcutaneous 70 Chronic Myeloid Leukemia 70 Metastatic Breast Cancer 70 Combo Therapy 70 Vaginal Gel 70 Tablet Formulation 70 Artery Disease 70 Interferon Alpha 70 Acute Heart Failure 70 Metastatic Pancreatic Cancer 70 Brain Atrophy 70 Clostridium difficile Infection 70 Announces FDA Clearance 70 Post Operative 70 IND Application 70 Intracerebral Hemorrhage 70 Initiate Phase 70 Significant Improvement 70 Cholesterol Levels 70 Acute Coronary Syndromes 70 Bypass Surgery 70 Teva Provides Update 70 Melphalan 70 Osteoarthritis Patients 70 Files IND 70 Regimens 70 Oral Cladribine 70 Phase III Pivotal Trial 70 Catheter Ablation 70 Successfully Treats 70 Erectile Dysfunction Drug 70 Thrombotic 70 Chronic Heart Failure 70 Cognitive Impairment 70 Cancer Treatments 70 Cardiogenic Shock 70 Receives Positive Opinion 70 Improves Quality 70 Reduces Pain 70 Long Term Survival 70 Mycophenolate Mofetil 70 Hormone Therapy 70 Symptom Improvement 70 Presents Preclinical Data 70 Dose Ranging Study 70 Advanced Solid Tumors 70 Pulmonary Arterial Hypertension 70 Demonstrate Significant 70 Protease Inhibitors 70 Confirms Efficacy 70 Severe Psoriasis 70 Prolongs Life 70 Extended Release 70 Oral Anticoagulant 70 Potentially Fatal 70 Fondaparinux 70 Abciximab 70 Symptom Relief 70 First Patient Enrolled 70 Clinical Outcomes 70 FDA Accepts 70 Clinical Study 70 Randomized Placebo Controlled Trial 70 Expanded Indication 70 Fludarabine 70 Balloon Angioplasty 70 Hematological Malignancies 70 Orthostatic Hypotension 70 Commonly Prescribed 70 Estrogen Therapy 70 Cell Lymphoma 70 Risedronate 70 Paraplatin ® 70 Spinal Fusion 70 Prostate Cancer Vaccine 70 FDA Panel Recommends 70 Emerging Therapies 70 Gene Linked 70 Presents Positive 70 Left Ventricular 70 Drug Eluting Stent 70 Novel Inhibitor 70 Therapy Reduces 69 Benign Prostatic Hyperplasia 69 Lenalidomide 69 Initiates Phase II 69 Adverse Effects 69 Venous Thrombosis 69 Newly Diagnosed Patients 69 Epilepsy Drug 69 Pharmacokinetics PK 69 Bladder Cancer 69 Initiates Phase 69 Obesity Linked 69 FDA Approves Drug 69 Endometrial Cancer 69 Recurrent Ovarian Cancer 69 Drug Fails 69 Minimally Invasive Treatment 69 Mylan Receives Approval 69 Relapsed Refractory Multiple Myeloma 69 Juvenile Idiopathic Arthritis 69 Recurrent Breast Cancer 69 Mitral Regurgitation 69 Patency 69 Blood Pressure Drug 69 Stem Cell Transplants 69 Prevent Stroke 69 alfa 2a 69 Unstable Angina 69 Genes Linked 69 Pneumococcal Vaccine 69 Myocardial Infarction Study 69 Parathyroid Hormone 69 Posaconazole 69 Treatment Naive HIV 69 Achieves Primary Endpoint 69 Oral Formulation 69 Rotavirus Vaccine 69 Phase Ib Clinical Trial 69 Ranolazine 69 Levels Linked 69 Polymerase Inhibitor 69 Myocardial Ischemia 69 Lung Tumors 69 Elevated Levels 69 Neuroprotective Effects 69 Showed Significant 69 Anticancer Drug 69 Percutaneous Coronary Intervention 69 Ischemic 69 Induces 69 Telaprevir VX 69 Irinotecan 69 Invasive Fungal Infections 69 Infarct 69 Prostate Surgery 69 ST Segment Elevation 69 Randomized Double Blind Placebo 69 Confirmatory Phase 69 Drug Eluting Stents 69 Intravitreal 69 Cholesterol Drugs 69 Combination Clinical Trial 69 Immune Responses 69 Stenting 69 Preterm Delivery 69 Blocked Arteries 69 Interferon Alfa 69 Mayo Clinic Study Finds 69 Prostate Biopsy 69 Study Confirms 69 Abdominal Pain 69 Migraine Drug 69 Nebulized 69 Chronic Renal Failure 69 PRN FDA Approves 69 Sirolimus Eluting 69 Combination REOLYSIN R 69 Bone Fractures 69 Pulmonary Artery 69 Cilostazol 69 Being Studied 69 Anti TNF 69 Initiates Clinical 69 Genes Predict 69 Transplant Patients 69 Double Blind Randomized 69 Novel Mechanism 69 Randomized Comparison 69 Novel Treatments 69 Recurrent Stroke 69 Cholesterol Drug 69 Septic Shock 69 Positive Opinion 69 Endovascular Treatment 69 Surgery Performed 69 Blood Thinner 69 Skeletal Muscle 69 Acute Myocardial 69 Exacerbation 69 Multicenter Randomized 69 Chemotherapy Regimen 69 Paclitaxel Carboplatin 69 Allogeneic 69 Renal Artery 69 Hemolysis 69 Drug Coated Stents 69 Cardiac Function 69 Radiation Dose 69 Aortic Valve 69 NICE Recommends 69 Predict Response 69 Dosed 69 Darbepoetin Alfa 69 Study Evaluates 69 Urinary Tract Infections 69 Randomized Controlled Trials 69 Lung Injury 69 Solid Tumors 69 Collaborators Present 69 Postmenopausal 68 Surgical Procedures 68 Initiates Enrollment 68 Efficacy Results 68 Study Shows Benefits 68 Treating Heart Failure 68 Randomized Controlled 68 Dose Finding 68 Hepatitis B Vaccine 68 Renal Cancer 68 Predict Risk 68 CYPHER R Sirolimus Eluting 68 Antiplatelet Therapy 68 Non Invasive Treatment 68 Drug Resistant 68 Cypher Sirolimus 68 Enlarged Prostate 68 Stress Urinary Incontinence 68 Sustained Virologic Response 68 Asthma Symptoms 68 Treat Anemia 68 Smoking Linked 68 Acute Migraine 68 Coronary Stents 68 Chemotherapeutic Agents 68 Bone Fracture 68 Demonstrates Sustained 68 Heart Attacks 68 Anticoagulant 68 Shows Statistically Significant 68 Preterm Infants 68 Robotic Assisted 68 Preclinical Study 68 Psoriasis Drug 68 Reduce Mortality 68 Hypercholesterolemia 68 Diabetic Neuropathic Pain 68 Intravenous Formulation 68 Metabolic Efficiency 68 Test Detects 68 Restenosis 68 Serious Infections 68 Hospital Acquired Pneumonia 68 Kinase Inhibitor 68 Coronary Arteries 68 Potent Antiviral Activity 68 R lenalidomide 68 Tyrosine Kinase Inhibitor 68 Cognitive Function 68 Cognitive Decline 68 Radiofrequency Ablation RFA 68 Interferon Beta 68 Colorectal Adenomas 68 Lung Cancer Drug 68 Prolongs 68 Clinical Study Shows 68 Liver Tumors 68 Infliximab 68 Mg Usa 68 Kidney Failure 68 Tyrosine Kinase Inhibitors 68 Cocaine Addiction 68 Shown Effective 68 Successfully Completes Phase 68 Who Underwent 68 Anti Clotting Drug 68 Cardiac Resynchronization 68 Insulin Resistance 68 Enrolls First 68 Virus Infection 68 Subtypes 68 Antiplatelet 68 Antidepressants Linked 68 Coronary Artery Bypass Graft 68 Replacement Therapy 68 Migraine Pain 68 Phase IIa Trial 68 Drug Coated Stent 68 Pemetrexed 68 Glucose Levels 68 Prognostic Factors 68 Hsp# Inhibitor 68 Pegylated 68 Menopausal Women 68 Migraine Headaches 68 Seasonal Allergic Rhinitis 68 Depressive Symptoms 68 Recombinant Human 68 Primary Hypercholesterolemia 68 Placebo Controlled 68 Brentuximab Vedotin SGN 68 Desvenlafaxine Succinate 68 Chronic Bronchitis 68 Recurrent Prostate Cancer 68 Hip Fractures 68 Based Regimens 68 Antipsychotic 68 Prospective Randomized Trial 68 Diffuse Large B 68 Diabetic Nephropathy 68 Coronary Artery 68 Aneurysm Repair 68 Drug Prevents 68 Prophylaxis 68 Thrombus 68 Uterine Fibroid Embolization 68 Diabetic Foot Ulcers 68 Infarction 68 Malignancies 68 Neovascular Age Related Macular 68 HCV Genotype 68 Cancer Recurrence 68 Prognostic Significance 68 Vertebroplasty 68 Breast Tumors 68 Platinol ® 68 Therapeutic Efficacy 68 Eluting Stent 68 Chronic Lymphocytic Leukemia 68 Randomized Evaluation 68 Adjunctive 68 Acute Attacks 68 Severe Asthma 68 JAK2 Inhibitor 68 Gemcitabine 68 Postherpetic Neuralgia 68 Abstracts Accepted 68 Phospholipase A2 68 Comorbidities 68 Decitabine 68 Topical Treatment 67 Antibiotic Treatment 67 Contrast Agent 67 TNF Blockers 67 Surgical Treatment 67 Demonstrates Statistically Significant 67 Oral Mucositis 67 Cancer Cells 67 Phase III Clinical Trials 67 Randomised Trial 67 Antifungal 67 Osteoporotic 67 Survival Rate 67 Targeted Therapies 67 Gastrointestinal Disorders 67 Antidepressant Use 67 Lymph Node 67 Hip Fracture 67 Clinically Proven 67 Progressive Multifocal Leukoencephalopathy 67 FDA Clearance 67 Antipsychotic Medications 67 Visceral Fat 67 Carcinoma 67 Vaccine Adjuvant 67 Occlusive Disease 67 Tumor Progression 67 Carotid Endarterectomy 67 Guidelines Issued 67 Gets FDA Clearance 67 Life Threatening 67 Diabetic Foot Ulcer 67 Relapsed Refractory Aggressive 67 Myelofibrosis 67 Community Acquired Pneumonia 67 Early Diagnosis 67 Bone Marrow Cells 67 Aggressive Prostate Cancer 67 Primary Endpoint 67 REMINDER ORLive Presents 67 Clopidogrel 67 Parenteral Nutrition 67 Corticosteroid 67 Taxane 67 Prostatectomy 67 Hemorrhagic Stroke 67 Severe Acne 67 Proves Successful 67 Mortality Risk 67 Guidelines Recommend 67 Sandostatin R 67 Phase 1b Clinical Trial 67 Gene Variants 67 Rheumatoid Arthritis Drug 67 Study Shows Significant 67 MR Angiography 67 External Beam 67 Poster Presentations 67 Esophageal 67 Genes Identified 67 Blood Pressure Reduction 67 Chemotherapy Induced 67 Partial Nephrectomy 67 alpha 2a 67 Genes Associated 67 Carcinomas 67 Laryngeal Cancer 67 See CLINICAL PHARMACOLOGY 67 Cancer Patients Treated 67 Lowers Blood Pressure 67 Hyperlipidemia 67 Hematological Cancers 67 Controlled Clinical Trial 67 Lung Function 67 Deep Venous Thrombosis 67 Percutaneous Tibial Nerve Stimulation 67 Monoclonal Antibody 67 Study Suggests 67 Oral Calcitonin 67 Cardiotoxicity 67 Dose Ranging 67 Novel Antibiotic 67 Panic Disorder 67 Diabetic Macular Edema 67 Intracranial Aneurysms 67 Endovascular Repair 67 Coronary Angiography 67 Skin Lesions 67 Active Rheumatoid Arthritis 67 PEGINTRON TM 67 Heartburn Drugs 67 Adenoma 67 ritonavir boosted 67 Mg Uk 67 Antitumor 67 Thromboembolism 67 Therapy Shows Promise 67 Clinical Trial Data 67 Systemic Sclerosis 67 Schizophrenia Drug 67 Milestone Payment 67 Metastatic Disease 67 Colorectal Cancers 67 Secondary Endpoints 67 Tacrolimus 67 Immune Cells 67 Blood Pressure Drugs 67 Multicenter Study 67 Atypical Antipsychotic 67 Receptor Antagonist 67 Randomized Phase II 67 Inflammatory Markers 67 Hepatitis C Virus 67 Treatment Shows Promise 67 Etanercept 67 Urinary Incontinence 67 Anticoagulants 67 Investigational Oral 67 TO AVOID PREGNANCY WHILE 67 HDAC Inhibitor 67 Overweight Obese 67 Gastrointestinal Stromal Tumors 67 Pain Relievers 67 Atrial Fibrillation Patients 67 Hip Replacement Surgery 67 Pregnancy Linked 67 Blood Pressure Lowering 67 Bloodstream Infections 67 Renal Insufficiency 67 NAVISTAR R 67 Renal Cell Cancer 67 Peripheral Arterial 67 Arterial Disease 67 Autoimmune Diseases 67 Non Invasive 67 Uterine Fibroids 67 Hepatitis C Treatment 67 Viral Infection 67 Protein Linked 67 Patent Covering 66 bone marrow reticulin deposition 66 Coronary Artery Bypass Surgery 66 Antiviral Therapy 66 Renal Tumors 66 Suppresses 66 Receptor Agonist 66 Mesalamine 66 Valsartan 66 Vaccine Candidate 66 Anticancer Drugs 66 Bipolar Depression 66 Gum Disease 66 Gene Variation 66 Embolic 66 Breast Cancer Cells 66 Paclitaxel Eluting 66 Prostate Tumors 66 Mouse Models 66 Vildagliptin 66 Tigecycline 66 cinacalcet 66 dual endothelin receptor antagonist 66 Skin Cancers 66 Stereotactic Body Radiation Therapy 66 Asthma Treatment 66 FOLFOX6 66 Unstable Angina Non 66 Varicose Veins 66 Be Treated 66 Generic Versions 66 First Patient Treated 66 Initiates Clinical Trials 66 Resection 66 Capsules CII 66 Antiviral Drugs 66 Adalimumab 66 CT Angiography 66 Statin Drugs 66 ORENCIA ® 66 Oral Contraceptive 66 Antihypertensive 66 Could Save Lives 66 Nucleoside 66 Receives Orphan Drug 66 Testosterone Gel 66 Dosing Regimen 66 Human Monoclonal Antibody 66 Meet Primary Endpoint 66 Organ Rejection 66 Could Prevent 66 IND Filing 66 Endothelial Cells 66 Progenitor Cells 66 Novel Compound 66 Vitamin D Linked 66 CCX# B 66 Implantable Cardioverter Defibrillator 66 Retreatment 66 Epilepsy Drugs 66 Holds Promise 66 Interferon Gamma 66 Valopicitabine NM# 66 Liver Injury 66 Anemia Drug 66 Study Examines 66 Vitro Activity 66 Acute Pancreatitis 66 Inhaled Nitric Oxide 66 Generalized Anxiety Disorder 66 Electrical Stimulation 66 Lipid Levels 66 Aliskiren 66 Asymptomatic 66 Oral Contraceptives 66 Renal Failure 66 Milestone Achieved 66 Paroxysmal Atrial Fibrillation 66 AnaSpec Introduces 66 Implantable Defibrillator 66 Inhaled Steroids 66 Nicotine Vaccine 66 Lanthanum Carbonate 66 Immunosuppressant 66 Camptosar ® 66 achieved CCyR 66 ARIXTRA R 66 Tumor Targeting 66 Pancreatic Adenocarcinoma 66 Antiangiogenic 66 sunitinib Sutent 66 Treating Depression 66 Randomized Clinical Trials 66 Enzyme Replacement Therapy 66 Complication Rates 66 Malignant Glioma 66 Pafuramidine 66 RNAi Therapeutic 66 Begins Dosing 66 Anti Inflammatory 66 Myelodysplastic Syndrome MDS 66 administered concomitantly 66 abacavir Ziagen 66 Pharmacodynamics 66 Antibiotic Use 66 Autoimmune Disease 66 Prostatic 66 Liver Cancer 66 Nerve Pain 66 Blood Vessel 66 Nymox NX 66 Insulin Therapy 66 Moderate Drinking 66 ER Visits 66 Immunomedics Announces 66 Shingles Vaccine 66 Systematic Review 66 Chemotherapy Induced Anemia 66 Tumor Cell 66 Testosterone Patch 66 Phase 2a Study 66 Epratuzumab 66 Blood Vessels 66 Leucovorin 66 Gene Mutations 66 Intraocular Pressure 66 FASLODEX 66 Schizophrenia Treatment 66 Neoplasms 66 Sulfonylurea 66 Natalizumab 66 Bazedoxifene 66 Cystectomy 66 Prostate Cancer Recurrence 66 Achieves Milestone 66 5 Fluorouracil 66 Sipuleucel T 66 Antipsychotic Drugs 66 Intra Arterial 66 Tezampanel 66 leukopenia pancytopenia thrombocytopenia 66 Drug Combinations 66 Advanced Gastric Cancer 66 Trial Halted 66 ® lenalidomide 66 Fast Track Status 66 Heel Pain 66 FDA Warns 66 unfractionated heparin UFH 66 Suicidality 66 Angiogenic 66 FDA APPROVES 66 Disease Modification 66 Bronchodilator 66 Allergic Reactions 66 Study Casts Doubt 65 PEGylated Fab fragment 65 Metabolic Disorder 65 MEK Inhibitor 65 FDA Approval 65 Atopic Dermatitis 65 Periodontal Disease 65 Impairs 65 5 FU leucovorin 65 Announces Presentation 65 Low Density Lipoprotein Cholesterol 65 Irregular Heartbeat